Respiri: Extends US partnership with Access Telehealth
Respiri Extends US partnership with Access TelehealthRespiri (RSH) signs a second, five-year, non-exclusive distribution and marketing agreement with Access Telehealth in the United...
Respiri: Receives FDA tick for Wheezo
Respiri (RSH) has received United States Food and Drug Administration (FDA) clearance for its wheezing aid, Wheezo
Wheezo monitors wheezing to manage and...

